Creating Designer Engineered Extracellular Vesicles for Diverse Ligand Display, Target Recognition, and Controlled Protein Loading and Delivery.
Saved in:
| Title: | Creating Designer Engineered Extracellular Vesicles for Diverse Ligand Display, Target Recognition, and Controlled Protein Loading and Delivery. |
|---|---|
| Authors: | Ivanova A; Discovery Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, Mölndal, 431 50, Sweden., Badertscher L; Translational Genomics, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, Mölndal, 431 50, Sweden., O'Driscoll G; Discovery Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, Mölndal, 431 50, Sweden.; Advanced Drug Delivery, Pharmaceutical Sciences, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, Mölndal, 431 50, Sweden., Bergman J; Medicinal Chemistry, Research and Early Development Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, Mölndal, 431 50, Sweden., Gordon E; Discovery Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, Mölndal, 431 50, Sweden., Gunnarsson A; Structure and Biophysics, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, Mölndal, 431 50, Sweden., Johansson C; Clinical Pharmacology and Safety Sciences, Sweden Imaging Hub, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, Mölndal, 431 50, Sweden., Munson MJ; Advanced Drug Delivery, Pharmaceutical Sciences, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, Mölndal, 431 50, Sweden., Spinelli C; Research Institute of the McGill University Health Centre, Glen Site, McGill University, Montreal, Quebec, H4A 3J1, Canada., Torstensson S; Translational Genomics, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, Mölndal, 431 50, Sweden., Vilén L; DMPK, Research and Early Development Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, Mölndal, 431 50, Sweden., Voirel A; Medicinal Chemistry, Research and Early Development Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, Mölndal, 431 50, Sweden., Wiseman J; Translational Genomics, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, Mölndal, 431 50, Sweden., Rak J; Research Institute of the McGill University Health Centre, Glen Site, McGill University, Montreal, Quebec, H4A 3J1, Canada., Dekker N; Discovery Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, Mölndal, 431 50, Sweden., Lázaro-Ibáñez E; Discovery Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, Mölndal, 431 50, Sweden.; Advanced Drug Delivery, Pharmaceutical Sciences, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, Mölndal, 431 50, Sweden. |
| Source: | Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2023 Dec; Vol. 10 (34), pp. e2304389. Date of Electronic Publication: 2023 Oct 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: WILEY-VCH Country of Publication: Germany NLM ID: 101664569 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2198-3844 (Electronic) Linking ISSN: 21983844 NLM ISO Abbreviation: Adv Sci (Weinh) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37867228 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Creating Designer Engineered Extracellular Vesicles for Diverse Ligand Display, Target Recognition, and Controlled Protein Loading and Delivery. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ivanova+A%22">Ivanova A</searchLink>; Discovery Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, Mölndal, 431 50, Sweden.<br /><searchLink fieldCode="AU" term="%22Badertscher+L%22">Badertscher L</searchLink>; Translational Genomics, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, Mölndal, 431 50, Sweden.<br /><searchLink fieldCode="AU" term="%22O'Driscoll+G%22">O'Driscoll G</searchLink>; Discovery Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, Mölndal, 431 50, Sweden.; Advanced Drug Delivery, Pharmaceutical Sciences, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, Mölndal, 431 50, Sweden.<br /><searchLink fieldCode="AU" term="%22Bergman+J%22">Bergman J</searchLink>; Medicinal Chemistry, Research and Early Development Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, Mölndal, 431 50, Sweden.<br /><searchLink fieldCode="AU" term="%22Gordon+E%22">Gordon E</searchLink>; Discovery Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, Mölndal, 431 50, Sweden.<br /><searchLink fieldCode="AU" term="%22Gunnarsson+A%22">Gunnarsson A</searchLink>; Structure and Biophysics, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, Mölndal, 431 50, Sweden.<br /><searchLink fieldCode="AU" term="%22Johansson+C%22">Johansson C</searchLink>; Clinical Pharmacology and Safety Sciences, Sweden Imaging Hub, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, Mölndal, 431 50, Sweden.<br /><searchLink fieldCode="AU" term="%22Munson+MJ%22">Munson MJ</searchLink>; Advanced Drug Delivery, Pharmaceutical Sciences, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, Mölndal, 431 50, Sweden.<br /><searchLink fieldCode="AU" term="%22Spinelli+C%22">Spinelli C</searchLink>; Research Institute of the McGill University Health Centre, Glen Site, McGill University, Montreal, Quebec, H4A 3J1, Canada.<br /><searchLink fieldCode="AU" term="%22Torstensson+S%22">Torstensson S</searchLink>; Translational Genomics, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, Mölndal, 431 50, Sweden.<br /><searchLink fieldCode="AU" term="%22Vilén+L%22">Vilén L</searchLink>; DMPK, Research and Early Development Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, Mölndal, 431 50, Sweden.<br /><searchLink fieldCode="AU" term="%22Voirel+A%22">Voirel A</searchLink>; Medicinal Chemistry, Research and Early Development Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, Mölndal, 431 50, Sweden.<br /><searchLink fieldCode="AU" term="%22Wiseman+J%22">Wiseman J</searchLink>; Translational Genomics, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, Mölndal, 431 50, Sweden.<br /><searchLink fieldCode="AU" term="%22Rak+J%22">Rak J</searchLink>; Research Institute of the McGill University Health Centre, Glen Site, McGill University, Montreal, Quebec, H4A 3J1, Canada.<br /><searchLink fieldCode="AU" term="%22Dekker+N%22">Dekker N</searchLink>; Discovery Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, Mölndal, 431 50, Sweden.<br /><searchLink fieldCode="AU" term="%22Lázaro-Ibáñez+E%22">Lázaro-Ibáñez E</searchLink>; Discovery Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, Mölndal, 431 50, Sweden.; Advanced Drug Delivery, Pharmaceutical Sciences, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, Mölndal, 431 50, Sweden. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101664569%22">Advanced science (Weinheim, Baden-Wurttemberg, Germany)</searchLink> [Adv Sci (Weinh)] 2023 Dec; Vol. 10 (34), pp. e2304389. <i>Date of Electronic Publication: </i>2023 Oct 22. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22WILEY-VCH%22">WILEY-VCH </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>101664569 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2198-3844 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221983844%22">21983844 </searchLink><i>NLM ISO Abbreviation: </i>Adv Sci (Weinh) <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37867228 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/advs.202304389 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e2304389 Titles: – TitleFull: Creating Designer Engineered Extracellular Vesicles for Diverse Ligand Display, Target Recognition, and Controlled Protein Loading and Delivery. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ivanova A – PersonEntity: Name: NameFull: Badertscher L – PersonEntity: Name: NameFull: O'Driscoll G – PersonEntity: Name: NameFull: Bergman J – PersonEntity: Name: NameFull: Gordon E – PersonEntity: Name: NameFull: Gunnarsson A – PersonEntity: Name: NameFull: Johansson C – PersonEntity: Name: NameFull: Munson MJ – PersonEntity: Name: NameFull: Spinelli C – PersonEntity: Name: NameFull: Torstensson S – PersonEntity: Name: NameFull: Vilén L – PersonEntity: Name: NameFull: Voirel A – PersonEntity: Name: NameFull: Wiseman J – PersonEntity: Name: NameFull: Rak J – PersonEntity: Name: NameFull: Dekker N – PersonEntity: Name: NameFull: Lázaro-Ibáñez E IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2023 Dec Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 2198-3844 Numbering: – Type: volume Value: 10 – Type: issue Value: 34 Titles: – TitleFull: Advanced science (Weinheim, Baden-Wurttemberg, Germany) Type: main |
| ResultId | 1 |